Comprehensive information about experimentally validated enhancers
| Enhancer ID: | E_01808 |
| Species: | Homo sapiens |
| Position : | chr11:5225440-5225500 |
| Year: | 2023 |
| Title: | Therapeutic adenine base editing of human hematopoietic stem cells |
| Genome Build: | hg38 |
| Enhancer Type: | Enhancer |
| Condition: | Normal |
| Disease Name: | -- |
| PMID: | 36639729 |
| MONDO: | |
| Tissue: | Bone Marrow |
| Tissue Ontology ID: | UBERON:0002371 |
| Cell Source: | CD34+ hematopoietic stem/progenitor cells |
| CVCL ID: | |
| Cell Type: | hematopoietic stem cell |
| Cell Ontology ID: | CL:0001029 |
| Experiment Type: | Functional perturbation assay, Enhancer activity assay |
| High Throughput Method: | RNA-seq |
| Low Throughput Method: | Adenine base editing, RT-RT-qPCR, RP-HPLC |
| Target gene : | HBG1 |
| TF name : |
| Regulatory State : | Silenced |
| GeneName | Pathway Name | Source | Gene Number |
|---|
| Enhancer ID | Position | Tissue | Cell | Disease |
|---|---|---|---|---|
| E_01640 | chr11:5225000-5226000 | Embryonic Kidney | embryonic kidney cell | -- |
| E_01641 | chr11:5225000-5226000 | Cervix | cervical adenocarcinoma cell | cervical cancer |
| E_01642 | chr11:5225000-5226000 | Blood | chronic myeloid leukemia cell | chronic myeloid leukemia |
| E_01643 | chr11:5225000-5226000 | Bone | osteosarcoma cell | osteosarcoma |